CPHI China 2025 idzachitika kuyambira Juni 24-26, 2025, ku Shanghai New International Expo Center (SNIEC). Kupitilira ma square metres opitilira 230,000, mwambowu ukuyenera kuchititsa owonetsa 3,500 ndikukopa akatswiri opitilira 100,000. Monga imodzi mwazinthu zazikulu kwambiri komanso zotsogola kwambiri zamalonda ku Asia, CPHI China imapereka nsanja yosayerekezeka yolumikizirana, ukadaulo, ndi chitukuko cha bizinesi.
 
Za JYMed
 
JYMed ndi kampani yaukadaulo yapamwamba yopangira mankhwala yomwe imayang'ana kwambiri kafukufuku, chitukuko, kupanga, ndi malonda azinthu zopangidwa ndi peptide. Timaperekanso ntchito zophatikizika bwino za CDMO, kupereka mayankho osinthika a peptide kwamakasitomala azamankhwala, zodzoladzola, ndi azinyama padziko lonse lapansi.
 
Zogulitsa zathu zili ndi ma peptide API ambiri. Zogulitsa zamtundu wamtundu monga Semaglutide ndi Tirzepatide zakwanitsa kumaliza kusungitsa kwa US FDA DMF.

Kampani yathu yocheperako, Hubei JXBio, imagwiritsa ntchito mizere yapamwamba kwambiri ya peptide API yomangidwa kuti ikwaniritse miyezo ya cGMP yokhazikitsidwa ndi US FDA ndi NMPA yaku China. Malowa amakhala ndi mizere 10 yayikulu komanso yoyendetsa ndege, mothandizidwa ndi a robust pharmaceutical Quality Management System (QMS) komanso pulogalamu yokwanira ya Environmental Health and Safety (EHS).
 
JXBio yadutsa pakuwunika kwa GMP ndi US FDA ndi NMPA yaku China ndipo imadziwika ndi makampani opanga mankhwala padziko lonse lapansi chifukwa chochita bwino pa kayendetsedwe ka EHS, kuwonetsa kudzipereka kwathu pazabwino, chitetezo, komanso kusamalira zachilengedwe.

ZOPHUNZITSA ZABWINO

Lumikizanani nafe

Kuti mudziwe zambiri za malonda ndi ntchito zathu, chonde lemberani:
● Global API & Cosmetic Inquiries:+ 86-150-1352-9272
● Kulembetsa kwa API & CDMO Services (US & EU):+ 86-158-1868-2250
● Imelo: jymed@jymedtech.com
● Adilesi:Floors 8 & 9, Building 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen, China.